Results 251 to 260 of about 692,862 (304)
Some of the next articles are maybe not open access.
The vasodilatory beta-blockers
Current Hypertension Reports, 2007Although well established in treating hypertension and cardiovascular (CV) disease, clinical trial data suggest that beta-blockers (eg, atenolol) may be less effective than other antihypertensive classes in reducing stroke and CV mortality despite similar blood pressure (BP) reductions.
Michala E, Pedersen, John R, Cockcroft
openaire +2 more sources
European Journal of Clinical Pharmacology, 1982
In a randomized, blind crossover study in 14 hypertensive patients with asthma, involving placebo and chronically administered (3 weeks) equipotent beta1-blocking doses of atenolol 100 mg once daily and metoprolol 100 mg bid, atenolol and metoprolol produced a similar fall in blood pressure.
D S, Lawrence +3 more
openaire +2 more sources
In a randomized, blind crossover study in 14 hypertensive patients with asthma, involving placebo and chronically administered (3 weeks) equipotent beta1-blocking doses of atenolol 100 mg once daily and metoprolol 100 mg bid, atenolol and metoprolol produced a similar fall in blood pressure.
D S, Lawrence +3 more
openaire +2 more sources
BJOG: An International Journal of Obstetrics & Gynaecology, 1981
DRUGS that competitively antagonize the effects of catecholamines at beta-adrenoreceptors have been in clinical use since the mid-1960s.
openaire +3 more sources
DRUGS that competitively antagonize the effects of catecholamines at beta-adrenoreceptors have been in clinical use since the mid-1960s.
openaire +3 more sources
Psychiatric Services, 1984
Beta-adrenergic receptor blocking drugs, although not approved by the Food and Drug Administration for treatment of psychiatric disorders, have been used with increasing success in psychiatry. Many beta-blockers are now available, but only those that have high lipid solubility and thus readily penetrate the brain, such as propranolol and oxprenolol ...
R A, Dominguez, B J, Goldstein
openaire +2 more sources
Beta-adrenergic receptor blocking drugs, although not approved by the Food and Drug Administration for treatment of psychiatric disorders, have been used with increasing success in psychiatry. Many beta-blockers are now available, but only those that have high lipid solubility and thus readily penetrate the brain, such as propranolol and oxprenolol ...
R A, Dominguez, B J, Goldstein
openaire +2 more sources
Beta-blockers for hypertension
2007Two recent systematic reviews found first-line beta-blockers to be less effective in reducing the incidence of stroke and the combined endpoint of stroke, myocardial infarction, and death compared to all other antihypertensive drugs taken together. However, beta-blockers might be better or worse than a specific class of drugs for a particular outcome ...
C S, Wiysonge +6 more
openaire +2 more sources
Beta-blockers for hypertension
2012This review is an update of the Cochrane Review published in 2007, which assessed the role of beta-blockade as first-line therapy for hypertension.To quantify the effectiveness and safety of beta-blockers on morbidity and mortality endpoints in adults with hypertension.In December 2011 we searched the Cochrane Central Register of Controlled Trials ...
Charles Shey, Wiysonge +5 more
openaire +3 more sources
The American Journal of Cardiology, 1983
Beta-adrenoceptor antagonists are effective in the management of patients with mild-to-moderate hypertension. Noncardioselective agents, cardioselective agents and beta blockers with intrinsic sympathomimetic activity (ISA) are equally effective, provided they are used in equipotent doses.
openaire +2 more sources
Beta-adrenoceptor antagonists are effective in the management of patients with mild-to-moderate hypertension. Noncardioselective agents, cardioselective agents and beta blockers with intrinsic sympathomimetic activity (ISA) are equally effective, provided they are used in equipotent doses.
openaire +2 more sources
The American Journal of Cardiology, 2010
Beta blockers have been used in the treatment of cardiovascular conditions for decades. Despite a long history and status as a guideline-recommended treatment option for hypertension, recent meta-analyses have brought into question whether β blockers are still an appropriate therapy given outcomes data from other antihypertensive drug classes. However,
openaire +2 more sources
Beta blockers have been used in the treatment of cardiovascular conditions for decades. Despite a long history and status as a guideline-recommended treatment option for hypertension, recent meta-analyses have brought into question whether β blockers are still an appropriate therapy given outcomes data from other antihypertensive drug classes. However,
openaire +2 more sources
Beta blockers in hypertension: a review
American Journal of Health-System Pharmacy, 1976The mechanisms of action, clinical use and untoward reactions of the beta-adrenergic blocking drugs, with particular attention to the role of these agents in the treatment of hypertension, are reviewed. Specific topics covered include the effect of beta-adrenergic blockade on the heart, renin secretion and the central nervous system; the efficacy and ...
openaire +3 more sources